With regard to its cognate receptor, CD19 + B cells of breast cancer patients displayed a trend towards lower GITR expression, whereas NK cells showed higher expression levels compared to HD, an observation which in T cells slightly failed to reach statistical significance. This evidence concerns the gene TNFRSF18 and breast carcinoma.